Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized-controlled Evaluation of Biomet 3i's T3 Implant System for Integration Success and the Preservation of Crestal Bone

NCT02161874 is registered in ClinicalTrials.gov with ZimVie as lead sponsor.

NCT NCT02161874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02161874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized-controlled Evaluation of Biomet 3i's T3 Implant System for Integration Success and the Preservation of Crestal Bone
Lead sponsor
ZimVie
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
July 31, 2020
Enrollment
40 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

partial edentulism, tooth disease